End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.77 CNY | -0.34% | -4.22% | +28.21% |
Mar. 25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
Mar. 22 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.98B 688M | Sales 2025 * | 5.69B 785M | Capitalization | 16.68B 2.3B |
---|---|---|---|---|---|
Net income 2024 * | 825M 114M | Net income 2025 * | 937M 129M | EV / Sales 2024 * | 3.09 x |
Net cash position 2024 * | 1.29B 178M | Net cash position 2025 * | 1.13B 156M | EV / Sales 2025 * | 2.73 x |
P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
18
x | Employees | - |
Yield 2024 * |
5.08% | Yield 2025 * |
5.4% | Free-Float | 51.07% |
1 day | -0.34% | ||
1 week | -4.22% | ||
Current month | +8.38% | ||
1 month | +14.35% | ||
3 months | +23.71% | ||
6 months | +44.08% | ||
Current year | +28.21% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Bin Xiao
CEO | Chief Executive Officer | 44 | 21-01-11 |
Xiao Jun Li
DFI | Director of Finance/CFO | 43 | 20-03-18 |
Yang Tang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Quan Liu
CHM | Chairman | 53 | 09-09-17 |
Na Tang
BRD | Director/Board Member | 48 | 22-11-16 |
Rong Deng
BRD | Director/Board Member | 46 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 4 M€ | -2.96% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 26.77 | -0.34% | 8,684,270 |
24-04-25 | 26.86 | -0.44% | 5,337,299 |
24-04-24 | 26.98 | -0.22% | 7,628,366 |
24-04-23 | 27.04 | -1.31% | 12,662,210 |
24-04-22 | 27.4 | -1.97% | 12,946,420 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.21% | 2.31B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 600750 Stock